The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
President Joe Biden’s proposal to have GLP-1 weight-loss drugs such as Ozempic and Mounjaro covered by Medicare and Medicaid ...
A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...
Only two in five people taking GLP-1 medication were confident they would maintain their weight loss after stopping the ...
Millions of Americans could have expanded Medicare and Medicaid to cover blockbuster weight loss drugs under a proposed ...
TennCare is federally required to cover GLP-1 drugs; of the $118M in the cost increase request, more than $76 million would ...
America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...
According to CMS estimates, passage of the rule would open access to the weight-loss medications to 3.4 million potential new ...